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Summary.-The primary reaction of the macrophage electrophoretic mobility test (MEM) and its modifications (viz. the interaction of myelin basic protein (MBP) and mononuclear cells) has been investigated. The binding of MBP to mononuclear cells
is rather weak, and on incubation with mononuclear cells the MBP is proteolytically degraded. A fast process leads to fragments with mol. wts in the range 9000-14,000, followed by a slower process leading to peptides smaller than 5000. Both binding and proteolytic degradation are the same for mononuclear cells from cancer patients and from control individuals.
The macrophage electrophoretic mo-
bility (MEM) test was introduced in 1970
as a method for the detection of cancer
(Field & Caspary, 1970). The procedure
can be described briefly as follows.
Peripheral-blood mononuclear cells are
incubated with an "antigen" preparation,
and as a second step the supernatant of
the first incubation is incubated with
indicator cells. The electrophoretic mo-
bility of the indicator cells was reported
to depend on whether the mononuclear
cells were prepared from the blood of
healthy controls or from cancer patients.
The test has been used by different groups
with several modifications (reviewed by
Mross, 1981). Brain extract, homogeneous
preparations of myelin basic protein
MBP (=encephalitogenic factor EF) or
extracts from cancer tissue have been used
as "antigens" (e.g. Dyson & Corbett,
1978; Muller et al., 1977); macrophages as
indicator cells have been substituted by
sheep erythrocytes tanned and stabilized
with sulphosalicylic acid (ETS) (Porzsolt
et al., 1975). Whatever the modifications,
the results are contradictory: some in-
vestigators claim to detect differences in
the response of healthy subjects and
cancer patients; others cannot reproduce
these findings (reviews by Porzsolt, 1978;
Mross & Wolfrum, 1980).
One of the most disturbing problems
concerning this test is that the molecular
basis for the measured electrophoretic
mobility changes is not yet known. Two
main concepts exist. One implies that
antigen-stimulated mononuclear cells from
sensitized donors produce a lymphokine
that slows the indicator cells. The other
concept assumes that the antigen is bound
or degraded by mononuclear cells, causing
a decrease in the antigen concentration
and therefore a diminished capacity to
influence the electrophoretic mobility of
the indicator cells.
Conclusive experimental evidence for
lymphokine production has not yet been
reported, whilst there are some indications
that proteolysis is important for the func-
tioning of the test (Dyson, 1979; Schu-
macher & Grol, 1981). If the latter is
true it should be possible to simplify the
test and to avoid the technical problemsINTERACTION OF MBP AND MONONUCLEAR CELLS
of cell electrophoresis by monitoring
directly the interaction between mono-
nuclear cells and antigen.
MATERIALS AND METHODS
Selection of subjects.-At this stage of the
investigation our main object was to try to
determine a difference between normal con-
trol subjects and cancer patients. We did not
discriminate between different forms of
cancer.
Preparation of mononuclear cells.-Human
peripheral blood was defibrinated or heparin-
ized and the mononuclear cells were prepared
by standard procedures using Ficoll-Hypaque
(Seromed) as the separation medium. The
cells were washed thoroughly to ensure that
no serum was retained in the preparations.
Hanks' balanced salt solution (HBSS) was
used for the final suspensions of the cells.
Besides lymphocytes the preparations con-
tained about 10-15% monocytes. For some
experiments the mononuclear cells were
activated before incubation with MBP. This
was done by incubating 3 x 106 cells in 1 ml
RPMI (Flow Laboratories), 5% foetal calf
serum (FCS), 2% penicillin/streptomycin
(PS) with PHA or TPA in concentrations as
indicated in Fig. 4 for 24 h at 37°C under an
atmosphere containing 5% CO2. The cells
were washed x 3 with 5 ml RPMI and re-
suspended in 1 ml RPMI containing MBP.
Preparation of MBP.-Bovine and human
MBP were prepared as described by Pitts et
al. (1976). Part of the bovine MBP was a gift
from Dr Wolfrum's group, Gottingen. The
preparations were more than 9500 pure as
judged by SDS-PAGE.
Radioiodination of MBP.-The radio-
iodination of MBP was carried out according
to Bolton (1977) using Chloramin-T. 100 ,ug
MBP was mixed with 50 ,tCi NaI251 (Amer-
sham Buchler). After adding 3 mg MBP in
HBSS, 1251-MBP was separated from un-
reacted Na1251 by gel filtration using a PD-10
column (Pharmacia) equilibrated with HBSS.
After filtration through a 0 24tm membrane
(Acrodisc, Gelman) the sterile solution was
stored at 4°C at a concentration of 1 mg 125L-
MBP/ml HBSS. The specific activity was
2-6 x 105 ct/min/,ug protein. The purity of
1251-MBP was analysed by SDS-PAGE as
described below and thin-layer chromato-
graphy. Cellulose plates (Merck) were run
in n-butanol/pyridine/acetic acid/bi-distilled
water (60:40:12:48 v/v). No loss of iodine
could be detected during the experimental
period.
Sample preparation. If not stated other-
wise, 3 x 106 mononuclear cells/ml were
incubated with 120 ,ug/ml=6-5 x 10-6M MBP
at 37TC using HBSS or, in the case of pro-
longed incubation, RPMI as buffer. Aliquots
were taken at various times as indicated in
the figures. Proteolysis was stopped in differ-
ent ways, depending on the subsequent
analytical procedure (v.i.). MBP incubated
with buffer alone and mononuclear cells
without added antigen were used as controls.
Electrophoresis.-Polyacrylamide gels at
12, 15 and 20% were prepared according to
Weber & Osborn (1969) or Lammli (1970).
Aliquots of the radioactive incubation mix-
tures were mixed with 5 ,ul of a bromophenol
blue solution and applied on to the gels. The
radioactive protein bands were localized by
autoradiography. cut out and the activity
determined in a gamma counter. The per-
centage of cleaved product was calculated
and corrections were made for nonspecific
degradation in the absence of mononuclear
cells. Nonradioactive incubation mixtures
were centrifuged before application on to the
gels. Protein bands were detected by staining
with Coomassie Brilliant Blue R 250.
Gel filtration.-Aliquots of the super-
natants of the incubation mixture were
separated by gel filtration using Ultrogel
AcA 202 (LKB), which has a fractionation
range of 1000 to 15,000 mol. wt. Fractions of
20 drops eluted from a column (1 1 x 35 cm)
equilibrated with 0-5M NaCl, 01M Tris/HCl
(pH 8.0) at room temperature were collected
and counted for radioactivity.
Binding of MBP to mononuclear cells.-
MBP and mononuclear cells (for concentra-
tions see Fig. 6) were incubated at room
temperature in HBSS with additional bovine
serum albumin (2 mg/ml) to avoid clumping
of the cells during the subsequent centrifuga-
tion. Separation of the cells from unbound
MBP was achieved as described by Pingoud
et al. (submitted). Briefly, aliquots were
layered on top of silicon oils AR 20 and AR
200 (Wackerchemie). The tubes were centri-
fuged for 15 s in a model 5120 Eppendorf
centrifuge, frozen in liquid N2 and cut into 2
parts. The radioactivity in the sediment and
supernatant was measured to calculate the
percentage of MBP bound to mononuclear
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cells. The layer ofsilicon oil between sediment
and supernatant showed no radioactivity.
RESULTS
The time course of the degradation of
MBP can be subdivided into 2 parts.
A rapid degradation to peptides of mol.
wts 9000-14,000 was followed by a
slower degradation to products of mol.
wts * 5000. The time course ofthe proteo-
lytic degradation and the size of the
products are the same for MBP from
human and bovine brain. This was
expected from a comparison ofthe amino-
acid sequences of the proteins from the
2 species (Dunkley & Carnegie, 1974).
They are identical in the regions of
preferential cleavage. The products of
the fast degradation can be analysed by
gel electrophoresis. The smaller peptides
resulting from the slower degradation
cannot conveniently be detected electro-
phoretically, and gel chromatography was
used as the analytical method instead.
Characterization ofthefastproteolytic
degradation
The mol. wts of the degradation pro-
ducts formed during the first 2 h of
incubation were determined in the Lammli
electrophoresis system. The first com-
ponent appearing has mol. wt 14,000,
followed by 1 or 2 components of
9000-11,000. After 20-24 h of incubation
these products are still detectable, though
there is no intact MBP left. There is an
apparent loss of protein because smaller
peptides cannot be stained in this system.
The observedfragmentation patternagrees
with the results ofBergstrand (1971), who
carried out a more extensive characteriza-
tion of the resulting peptides.
With a given amount of antigen the
proteolytic degradation is dependent on
the concentration of mononuclear cells.
Therefore all cleavage data were related
to mononuclear cell concentration, which
varied in different experiments. In order
to locate the proteolytic activity, mono-
nuclear cells were preincubated in HBSS,
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FIG. 1.-Fast proteolytic degradation ofMBP
by mononuclear cells. Protein concentra-
tion: 0-12 mg/ml MBP; concentration of
mononuclear cells in the incubation mix-
ture: 3 x 106/ml, data corrected to 106/ml
(0). Proteolytic activity of the super-
natants of mononuclear cells, preincubated
in HBSS for 90 min at 370C (A).
centrifuged andthe supernatant incubated
withMBP.
As can be seen from Fig. 1, degradation
by the supernatant is greatly reduced.
Most of the activity seems to be cell-
associated. The proteolytic activity can be
inhibited by inhibitors of serine proteases
c
0
0 L0
0
L.
a'
01-
40[
301
201
10-
0
0
0
S
000
000
90000
@0
00
00
0
0
00
*000
0000
00
0*0@
0
ControL Cancer
FIG. 2.-Comparison of the fast proteolytic
activity ofmono-nuclear cells from healthy
controls and cancer patients. Incubation
time: 30-min, concentrations as in Fig. 1.
Each point represents one person.
a
840INTERACTION OF MBP AND MONONUCLEAR CELLS
/
NA
A
3 6 12 24
Period of Incubation (h)
Fia. 3. Kinetics of the slow proteolytic degradlation of MBP. Fragments with mol wts > 10,000,
0;
- 5000, Aand < 1000, M.
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such as phenylmethanosulphonylfluoride
and trasylol. These experiments were
done qualitatively; their results are in
accordance with the more detailed studies
of Dyson (1981) (submitted).
Comparison of healthy controls and cancer
patients
Blood samples from 20 healthy persons
and 19 cancer patients were investigated.
Aliquots of the incubation mixtures were
withdrawn after 15, 30 and 60 min and
analysed. The degree of degradation after
30 min is shown in Fig. 2. Each point
represents the mean value of 2 analyses
using the mononuclear cells of one person.
The average of the 2 groups are 16-2 +
3.2% and 17-1 + 2.1% respectively (i.e.
not significantly different).
Characterization of the products of the slow
proteolytic degradation
After prolonged incubation of MBP the
proteolytic fragments of mol. wts 9000
and 14,000 are further degraded. Two
distinct peptides or groups of peptides
elute from Ultrogel AcA 202 with mol. wts
5000 and <1000 respectively. The
kinetics ofthis slow degradation are shown
in Fig. 3.
Nonspecific stimulation of the mono-
nuclear cells by mitogens such as PHA or
TPA before incubation with MBP en-
hances the proteolysis in a dose-dependent
manner (Fig. 4). It seems unlikely, there-
fore, that the slow degradation is due to
lysosomal enzymes secreted upon cell
lysis after prolonged incubation.
Comparison of healthy controls and cancer
patients
The blood samples of 6 healthy controls
were compared to those of 12 cancer
patients. The quantity of fragments with
mol. wts < 1000 was taken as a measure
of proteolysis (Fig. 5). The degree of
degradation varies widely even within the
control samples, but is not different for
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FIG. 4. Influence of nonspecific stimulation
of the mono-nuclear cells on the slow pro-
teolytic degradation of MBP. Incubation
time, 24 h; conditions as described under
Methods.
the 2 groups (mean values are 37-6 +
9-6% and 40-3 + 7-3% respectively).
Binding of MBP to mononuclear cells
Binding or internalization is a fast pro-
cess with a steady state reached after 5
min; 15 min was taken as standard incu-
bation time, during which the proteolytic
degradation at room temperature may be
neglected.
The degree ofbinding depends upon the
concentration of MBP and mononuclear
cells. Saturation could not be achieved,
even at high concentrations of MBP and
mononuclear cells. The binding isotherms
in Fig. 6 can beinterpreted as due to rather
weak binding to many sites. Our results
show that, in the concentration range
Control Cancer
FIG. 5. Comparison of the slow proteolysis
of MBP by mono-nuclear cells from
healthy controls and cancer patients. For
concentrations see Materials and Methods.
Incubation time, 24 h. Each point rep-
resents one person.
normal for the EMT or MEM test, < 1%
ofthe protein is bound.
The comparison of the binding capacity
ofmononuclear cells from 6 healthy donors
and 5 cancer patients is shown in Fig. 7.
No differences were detectable.
DISCUSSION
The aim ofthis study was to investigate
the molecular basis of the MEM test
and the EMT; i.e. to analyse the inter-
action of MBP and mononuclear cells,
the primary reaction of these tests. Two
effects were investigated that might
explain the claimed different capability
of mononuclear cells from cancer patients
and healthy controls to affect the electro-
phoretic mobility of indicator cells upon
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FIG. 6.-Binding isotherms of MBP to mono-
nuclear cells. Concentration of mono-
nuclear cells: 11 x 106/ml, *, 5.5 x 106/ml
0, 2-8 x 106/ml *. Incubation time, 15
min at room temperature.
incubation with MBP. These effects are
the proteolytic degradation of MBP by
mononuclear cells and the binding ofMBP
to those same cells. We were not interested
in the interaction of MBP and mono-
nuclear cellsper se, but only astheprimary
reaction in the test system of the EMT/
MEM test as used in various laboratories.
For that reason the mononuclear cells
were not further purified, and lympho-
cytes were investigated in a mixture with
monocytes. The incubation conditions
chosen were those describedin most papers
dealing with the clinical use of the MEM
test andthe EMT; consequently wedidnot
invest any effort in optimizing the condi-
tionsfor ourstudies.
The incubation time reported varies
greatly, from the 30-90 min of most
investigators, to 24 h (e.g. Douwes et al.,
1977; Tautz et al., 1977). During this
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FIG. 7.-Comparison of the binding of MBP
to mononuclear cells from healthy controls
and cancer patients. Concentration ofMBP
60 ,g/ml. Concentration of mononuclear
cells, 15-20 x 106/ml.
incubation, MBP is degraded by a proteo-
lytic activity associated with the mono-
nuclear cells. It is not clear, however,
where the proteolysis is located on the
cells or which species of the mononuclear
cells is responsible for the effects.
One can distinguish a fast degradation
during thefirst hours ofincubation leading
to a fragmentation of MBP to products
containing more than the half of the
original molecule, and a slower process
leading to peptides of mol. wt 5000 and
less.
The duration of the proteolysis is
dependent on incubation conditions,
mononuclear-cell and protein concentra-
tions, and varies from patient to patient.
This may be due in part to the inhomo-
geneity of the mononuclear cells.
Irrespective of these difficulties, there is
clearly no detectable difference between
cancer patients and healthy controls, in
the proteolytic activityofperipheral-blood
mononuclear cells. Our results are some-
what at variance with those published by
Fish et al. (1974). Qualitatively they found
a faster degradation of histone F2A1
1
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(=H2A) by peripheral-blood mononuclear
cell preparations from cancer patients
(n=5) than from those prepared from
healthy controls. This discrepancy may be
due to the different proteins used as
substrate in their study from the one we
used.
The binding of MBP to mononuclear
cells is very weak. It is not saturable even
at a concentration 5 times that normally
used. Under the conditions of the MEM
test/EMT, less than 1% of the protein is
bound or internalized by the mononuclear
cells. These findings exclude thepossibility
that adsorption as such plays a significant
role in the test. The amount of MBP that
is available to react with the indicator
cells in the second step of the EMT is not
significantly reduced.
What cannot be excluded by these
studies is the possibility that the small
amount of bound MBP could lead to a
different production of a lymphokine in
cancer patients and healthy controls. One
consideration argues against this hypo-
thesis, at least as a possible mechanism of
the EMT. To get a 10% reduction of the
electrophoretic mobility of the ETS by
MBP, a highly basic protein, a concentra-
tion of at least 30 ,ug/ml protein is needed
(Buurmann, unpublished result). This
amount of protein (1 jug per aliquot) is
easily detected in our electrophoretic
system. During all our electrophoretic
investigations we could never detect even
traces of a newly appearing protein, such
as a lymphokine, that might influence
electrostatically the ETS (dead cells which
cannot respond physiologically).
Though our data may not be representa-
tive statistically, they indicate that the
binding reaction between MBP and lym-
phocytes and the lymphocyte-associated
proteolytic activity towards MBP, are
unsuitable for the detection of cancer.
They furthermore show that the 2 most
obvious explanations for the claimed
specificity ofthe EMT and MEM test as a
cancer test can be excluded. This result,
and the accumulating negative experience
with the MEM test and the EMT as a
diagnostic tool (e.g. Hoffmann et al., 1981)
make us suspect that there is no rational
basis for the MEM test/EMT as a proce-
dure for detecting cancer in humans.
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